NEWSROOM
Accelerating the mHealth Revolution
Accelerating the mHealth Revolution; TouchDx Offers Free Leading Edge iPhone Medical Applications for Academicians and the Next Generation of Healthcare Providers
TouchDx enabling the mHealth revolution and challenging Business as Usual Medicine
San Diego, CA, May 11, 2010 - Touch Diagnostics (TouchDx) the leading developer of mHealth solutions for smartphone devices will begin releasing free "Edu" versions of its iPhone medical apps with the goal of empowering healthcare practitioners and patients, through hands on use of TouchDx medical apps. Beyond academic institutions and medical students, the "Edu" version sets out to educate and ready all healthcare consumers and providers to embrace and experience the mHealth revolution.
“For far too long, the medical community has been driven by the top down, command and control model. With mHealth, innovation and change will be powered by the individual patient and their healthcare provider”, stated Brent Gutekunst, CEO, of Touch Diagnostics. “That’s precisely why we are providing patient and doctor friendly applications on the most sophisticated platform available to the medical community…the smartphone. We are focusing on empowering both the doctor and the patient to define and control what’s best for them. We intend to be a disruptive force in business as usual medicine.”
Some of the free “Edu” version apps to be released include:
OKN+: To assess for optikinetic nystagmus
RedDesat: To identify possible optic nerve pathology
DigiTap: To assess fine motor skills in patients as part of a neurological work up
ReActDx: To assess fine motor skills and cognition
TremorTracer: Archimedes Spiral Test to assess and evaluate tremor
Today the worldwide population is approximately 6.8 billion, of which an astounding 4.6 billion own and use mobile phones - with an estimate of 5 billion by the end of 2010. In contrast, currently there are 1.8 billion internet users worldwide. With mobile phones being in the hands of nearly 75% of the world’s population, it is unequivocally the communication and technology platform of choice. Pairing the mobile phone’s accessibility, technical capabilities, portability, convenience, and global reach, TouchDx believes the mobile phone will revolutionize how medicine will be managed and delivered in the 21st Century.
Founded in 2009, Touch Diagnostics (TouchDx), is leading the mHealth revolution by providing healthcare practitioners and patients smartphone based solutions in order to facilitate better patient care, treatment and management. As pioneers in mHealth, TouchDx leverages the convenience, innovation and technical capabilities of the iPhone, to quantify the previously unquantifiable, enhance clinical surveillance, increase diagnostic sensitivity, and to yield better health outcomes for patients worldwide.
For additional information on the news that is the subject of this release please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it or visit www.touchdx.com.
TremorTracer Is Launched
TouchDx Releases TremorTracer™, an iPhone Tremor Assessment for Patients with Parkinson’s Disease, Multiple Sclerosis and Other Movement Disorders
TremorTracer the first iPhone App to quantify, assess and record tremor, increasing accuracy, ease & clinical yield.
San Diego, CA, March 23, 2010 - Touch Diagnostics (TouchDx) the leading developer of mHealth solutions for the iPhone, announced the introduction of TremorTracer™. TremorTracer™ provides physicians a unique and revolutionary tremor assessment with which to identify, record, and monitor longitudinal change in writing skills for patients with fine motor function deficits, due to tremor.
DigiTap Is Launched
Touch Diagnostics Lauches DigiTap™ iPhone App for Assessment of Multiple Sclerosis and Lou Gehrig’s Disease
iPhone app delivers portability and enhanced diagnostic sensitivity for neuroscience professionals.
San Diego, CA, Mar 2, 2010 - Touch Diagnostics launches the second medical diagnostic iPhone application for healthcare practitioners to assess and monitor neurodegenerative disease.
OKN+ Is Launched
Touch Diagnostics Launches OKN+™ iPhone App for Visual Deficits as an Indicator of Neurodegenerative Disease
iPhone App replaces yesterday’s manual devices, increasing diagnostic yield.
San Diego, CA, Feb 23, 2010 - Touch Diagnostics (TouchDx) launched today a new class of medical diagnostic iPhone applications for use by healthcare practitioners to assess and monitor neurodegenerative disease. The first of which is OKN+™, a medical diagnostic suite of assessments to detect visual deficits and includes three Optokinetic Nystagmus tests and the Red Desaturation test.
Touch Diagnostics Fact Sheet
Touch Diagnostics
Touch Diagnostics is a mobile health company leveraging the world’s most powerful technology platform to revolutionize healthcare. The smartphone is poised to have a more robust and immediate impact on how healthcare is delivered and managed, than any single technology in years. eHealth and eRecords focus on using technology to maximize the efficiencies in existing healthcare administration, mHealth and TouchDx are focused on changing the way medicine is imagined and executed.
As pioneers in mHealth, TouchDx leverages the convenience, innovation and technical capabilities of the iPhone, to quantify the previously unquantifiable, increase diagnostic sensitivity, and enhance clinical surveillance to yield better health outcomes for patients worldwide.
Products
Touch Diagnostics has developed and launched four medical applications for the iPhone: OKN+, DigiTap, ReActDx, and TremorTracer. The four applications have been made available in the last 30 days, and have been purchased and utilized by healthcare practitioners in 13 countries.
OKN+™ is a suite of assessments used for the detection of visual deficits as an indicator of neurodegenerative disease and optic nerve pathology.
DigiTap™ is a convenient, cost effective replacement of yesterdays, expensive and boxy Finger Tap machine. DigiTap™ is designed for healthcare practitioners to measure fine motor speed, motor control, and coordination in the upper and lower extremities by assessing finger tapping and toe tapping.
ReAct™ is for use in the neurosciences, including neuro-rehabilitation, to assess attention, fine motor skills, appendicular coordination, visual spatial processing, and reaction time.
TremorTracer™ provides physicians a tremor assessment with which to identify, record, and monitor longitudinal change in writing and tracing skills for patients with fine motor function deficits, due to tremor. TremorTracer offers the gold standard in written tremor assessments including the tracing of Archimedes Spirals and handwriting.
Executive Team
Founded in 2009 by a team of leading physicians and technology specialists, Touch Diagnostics’ goal is to employ this expertise, for the development of new and enhanced medical diagnostic assessments, aimed at changing the way healthcare is imagined and managed.